Victory Capital Management Inc Krystal Biotech, Inc. Transaction History

Victory Capital Management Inc

  • $99 Billion
  • Q3 2024

A detailed history of Victory Capital Management Inc transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 98,285 shares of KRYS stock, worth $15.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
98,285
Previous 143,865 31.68%
Holding current value
$15.2 Million
Previous $26.4 Million 32.35%
% of portfolio
0.02%
Previous 0.03%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
SELL
$174.7 - $213.66 $7.96 Million - $9.74 Million
-45,580 Reduced 31.68%
98,285 $17.9 Million
Q2 2024

Aug 05, 2024
BUY
$153.12 - $183.64 $1.38 Million - $1.66 Million
9,045 Added 6.71%
143,865 $26.4 Million
Q1 2024

May 03, 2024
SELL
$108.01 - $179.35 $4.11 Million - $6.83 Million
-38,059 Reduced 22.01%
134,820 $24 Million
Q4 2023

Feb 05, 2024
SELL
$96.0 - $128.29 $3.51 Million - $4.7 Million
-36,608 Reduced 17.48%
172,879 $21.4 Million
Q3 2023

Nov 06, 2023
BUY
$108.51 - $130.22 $1.35 Million - $1.62 Million
12,448 Added 6.32%
209,487 $24.3 Million
Q2 2023

Jul 27, 2023
SELL
$78.48 - $130.32 $1.18 Million - $1.97 Million
-15,091 Reduced 7.11%
197,039 $23.1 Million
Q1 2023

May 02, 2023
SELL
$72.39 - $84.27 $9.21 Million - $10.7 Million
-127,201 Reduced 37.49%
212,130 $17 Million
Q4 2022

Feb 09, 2023
BUY
$63.14 - $79.9 $2.26 Million - $2.85 Million
35,732 Added 11.77%
339,331 $26.9 Million
Q3 2022

Nov 02, 2022
BUY
$64.85 - $82.4 $17.9 Million - $22.8 Million
276,251 Added 1010.13%
303,599 $21.2 Million
Q2 2022

Aug 01, 2022
BUY
$48.93 - $73.47 $1.34 Million - $2.01 Million
27,348 New
27,348 $1.8 Million
Q1 2022

May 04, 2022
SELL
$51.99 - $72.11 $148,899 - $206,523
-2,864 Closed
0 $0
Q4 2021

Feb 07, 2022
BUY
$39.81 - $88.24 $114,015 - $252,719
2,864 New
2,864 $200,000
Q2 2021

Aug 03, 2021
SELL
$62.14 - $81.82 $172,500 - $227,132
-2,776 Closed
0 $0
Q1 2021

May 04, 2021
BUY
$59.42 - $85.46 $164,949 - $237,236
2,776 New
2,776 $214,000
Q4 2020

Feb 01, 2021
SELL
$40.64 - $61.38 $21.3 Million - $32.2 Million
-524,144 Closed
0 $0
Q3 2020

Nov 09, 2020
BUY
$37.76 - $48.49 $9.29 Million - $11.9 Million
246,047 Added 88.48%
524,144 $22.6 Million
Q2 2020

Aug 07, 2020
BUY
$37.03 - $60.0 $10.2 Million - $16.6 Million
276,508 Added 17401.38%
278,097 $11.5 Million
Q1 2020

May 04, 2020
SELL
$35.02 - $65.64 $18,035 - $33,804
-515 Reduced 24.48%
1,589 $69,000
Q4 2019

Feb 06, 2020
BUY
$33.17 - $65.23 $16,883 - $33,202
509 Added 31.91%
2,104 $117,000
Q4 2019

Feb 04, 2020
SELL
$33.17 - $65.23 $4,776 - $9,393
-144 Reduced 8.28%
1,595 $83,000
Q3 2019

Nov 12, 2019
BUY
$34.72 - $51.3 $60,378 - $89,210
1,739 New
1,739 $60,000

Others Institutions Holding KRYS

# of Institutions
306
Shares Held
24.2M
Call Options Held
483K
Put Options Held
364K
View Full List

About Krystal Biotech, Inc.

KRYS Quotes by TradingView
  • Ticker KRYS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,664,300
  • Market Cap $3.97B
  • Description
  • Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...
More about KRYS
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email